Basilea Pharmaceutica AG (BPMUF)
60.28
0.00 (0.00%)
USD |
OTCM |
Jun 29, 16:00
Basilea Pharmaceutica Cash from Investing (TTM) : -3.579M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2025 | -3.579M |
| June 30, 2025 | -1.933M |
| December 31, 2024 | -1.160M |
| June 30, 2024 | -0.4351M |
| December 31, 2023 | -1.155M |
| June 30, 2023 | 96.91M |
| December 31, 2022 | 94.88M |
| June 30, 2022 | -19.34M |
| December 31, 2021 | 4.156M |
| June 30, 2021 | 0.5026M |
| December 31, 2020 | -37.34M |
| June 30, 2020 | -17.03M |
| December 31, 2019 | -0.4068M |
| June 30, 2019 | 60.02M |
| December 31, 2018 | 59.99M |
| June 30, 2018 | -0.7228M |
| December 31, 2017 | -61.33M |
| June 30, 2017 | -61.16M |
| December 31, 2016 | 1.236M |
| June 30, 2016 | 31.29M |
| December 31, 2015 | 17.09M |
| June 30, 2015 | 34.54M |
| Date | Value |
|---|---|
| December 31, 2014 | 91.39M |
| June 30, 2014 | 5.018M |
| December 31, 2013 | -39.43M |
| June 30, 2013 | -43.35M |
| December 31, 2012 | -102.82M |
| June 30, 2012 | 82.01M |
| December 31, 2011 | 140.01M |
| June 30, 2011 | -52.49M |
| December 31, 2010 | -83.39M |
| June 30, 2010 | -42.90M |
| December 31, 2009 | 130.35M |
| June 30, 2009 | 209.79M |
| December 31, 2008 | 28.90M |
| June 30, 2008 | 100.37M |
| December 31, 2007 | -92.68M |
| June 30, 2007 | -189.37M |
| December 31, 2006 | 47.16M |
| June 30, 2006 | -35.76M |
| December 31, 2005 | -51.07M |
| June 30, 2005 | 32.93M |
| December 31, 2004 | -105.18M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Santhera Pharmaceuticals Holding AG | -0.1525M |
| BeOne Medicines Ltd. | -200.59M |
| AC Immune SA | -- |
| CRISPR Therapeutics AG | -422.79M |
| Idorsia Ltd. | -4.488M |